Biodegradable block copolymer-doxorubicin conjugates via different linkages: preparation, characterization, and in vitro evaluation.
暂无分享,去创建一个
Xiabin Jing | Shi Liu | Xuesi Chen | Xiuli Hu | Xuesi Chen | X. Jing | Xiuli Hu | Shi Liu | Yubin Huang | Yubin Huang
[1] H. Ringsdorf,et al. Polymeric Antitumor Agents on a Molecular and on a Cellular Level , 1981 .
[2] T. Okano,et al. Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. , 1991, Cancer research.
[3] A. Kabanov,et al. Anthracycline antibiotics non-covalently incorporated into the block copolymer micelles: in vivo evaluation of anti-cancer activity. , 1996, British Journal of Cancer.
[4] J. Kopeček,et al. HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[5] A. Kabanov,et al. Novel drug delivery systems based on the complexes of block ionomers and surfactants of opposite charge , 1999 .
[6] T. Okano,et al. Doxorubicin-loaded poly(ethylene glycol)-poly(beta-benzyl-L-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[7] K. Ulbrich,et al. Doxorubicin bound to a HPMA copolymer carrier through hydrazone bond is effective also in a cancer cell line with a limited content of lysosomes. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[8] T. Park,et al. Doxorubicin-conjugated biodegradable polymeric micelles having acid-cleavable linkages. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[9] K. Ulbrich,et al. Antibody-targeted Polymer–doxorubicin Conjugates with pH-controlled Activation , 2004, Journal of drug targeting.
[10] K. Brown,et al. Cell-specific delivery of a chemotherapeutic to lung cancer cells. , 2004, Journal of the American Chemical Society.
[11] Tae Gwan Park,et al. Folate receptor targeted biodegradable polymeric doxorubicin micelles. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[12] G. Hsiue,et al. Polymeric micelles with a pH-responsive structure as intracellular drug carriers. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[13] Theresa M. Allen,et al. Determination of Doxorubicin Levels in Whole Tumor and Tumor Nuclei in Murine Breast Cancer Tumors , 2005, Clinical Cancer Research.
[14] K. Ulbrich,et al. Polymeric micellar pH-sensitive drug delivery system for doxorubicin. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[15] Kazunori Kataoka,et al. Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy. , 2005, Bioconjugate chemistry.
[16] Jayant Khandare,et al. Polymer-drug conjugates: Progress in polymeric prodrugs , 2006 .
[17] Kazunori Kataoka,et al. Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. , 2006, Pharmacology & therapeutics.
[18] A. Chilkoti,et al. Structural optimization of a "smart" doxorubicin-polypeptide conjugate for thermally targeted delivery to solid tumors. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[19] Subbu S. Venkatraman,et al. Block Copolymer ‘Stealth’ Nanoparticles for Chemotherapy: Interactions with Blood Cells In Vitro , 2008 .
[20] K. Ulbrich,et al. Doxorubicin release is not a prerequisite for the in vitro cytotoxicity of HPMA-based pharmaceuticals: in vitro effect of extra drug-free GlyPheLeuGly sequences. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[21] Rassoul Dinarvand,et al. Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA–PEG–folate conjugate , 2008 .
[22] F. Greco,et al. Polymer-drug conjugates: current status and future trends. , 2008, Frontiers in bioscience : a journal and virtual library.
[23] Xuesi Chen,et al. Biodegradable amphiphilic block copolymers bearing protected hydroxyl groups: synthesis and characterization. , 2008, Biomacromolecules.
[24] X. Shuai,et al. Folate-functionalized polymeric micelle as hepatic carcinoma-targeted, MRI-ultrasensitive delivery system of antitumor drugs , 2008, Biomedical microdevices.
[25] K. Ulbrich,et al. Biological evaluation of polymeric micelles with covalently bound doxorubicin. , 2009, Bioconjugate chemistry.
[26] R. Duncan,et al. Poly(amidoamine) conjugates containing doxorubicin bound via an acid-sensitive linker. , 2009, Macromolecular bioscience.
[27] K. Ulbrich,et al. HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[28] B. Říhová. Clinical experience with anthracycline antibiotics-HPMA copolymer-human immunoglobulin conjugates. , 2009, Advanced drug delivery reviews.
[29] A. David,et al. E-selectin binding peptide-polymer-drug conjugates and their selective cytotoxicity against vascular endothelial cells. , 2009, Biomaterials.
[30] X. Jing,et al. Folate-conjugated micelles and their folate-receptor-mediated endocytosis. , 2009, Macromolecular bioscience.
[31] C. van Nostrum,et al. Micelles based on HPMA copolymers. , 2010, Advanced drug delivery reviews.